Aptevo Therapeutics
APVO
APVO
8 hedge funds and large institutions have $37.7M invested in Aptevo Therapeutics in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SC
Sessa Capital
New York
|
+$1.8M |
Top Sellers
1 |
![]()
JPMorgan Chase & Co
New York
|
-$1.45M |
2 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$981K |
3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$874K |
4 |
SIM
Spark Investment Management
New York
|
-$676K |
5 |
CL
CSS LLC
Chicago,
Illinois
|
-$592K |